Catalyst Wire Dossier Catalyst Wire Dossier

SB011

· Sterna Biologicals GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB011, covering 2017-01-13 to 2017-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema [Phase 2]

See pricing